Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Innoviva Inc (NASDAQ:INVA)

11.21
Delayed Data
As of 3:59pm ET
 +0.30 / +2.75%
Today’s Change
6.36
Today|||52-Week Range
16.62
+6.36%
Year-to-Date
No recent news for Innoviva Inc.

Today’s Trading

Previous close10.91
Today’s open10.88
Day’s range10.87 - 11.34
Volume587,792
Average volume (3 months)663,940
Market cap$1.2B
Dividend yield8.93%
Data as of 3:59pm ET, 08/25/2016

Growth & Valuation

Earnings growth (last year)+89.33%
Earnings growth (this year)+476.25%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+247.57%
P/E ratio65.9
Price/Sales17.94
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SAGESAGE Therapeutics In...+0.18+0.48%
ACHNAchillion Pharmaceut...0.000.00%
SRPTSarepta Therapeutics...-0.43-1.64%
DEPODepomed Inc-0.92-4.45%
Data as of 3:59pm ET, 08/25/2016

Financials

Next reporting dateOctober 27, 2016
EPS forecast (this quarter)$0.19
Annual revenue (last year)$67.8M
Annual profit (last year)-$18.8M
Net profit margin-27.68%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers

Search for Jobs